However, others reported that the over expression of FAM83B was negatively correlated with the survival in non-small cell lung carcinoma (NSCLC) patients and it was correlated with the activation of EGFR signal pathway and mutation of EGFR [6]. This evidence concerns the gene SACK1B and non-small cell lung carcinoma.